About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Case Report 
“Lazarus effect” in patient affected by lung adenocarcinoma carrying EGFR, CTNNB1, MET exon 11 and PIK3CA mutations treated with gefitinib
Nicole Conci, Filippo G. Dall’Olio, Vittoria Comellini, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni
Precision Cancer Medicine  
2020;
3:
23  
Case Report: Precision Oncology Tumor Board 
Prolonged immune checkpoint inhibitor response of a patient with a RET rearranged non-small cell lung cancer and high tumour mutational burden: case report and review of the literature
Safiye Dursun, Tom E. J. Theunissen, Xiaofei Li, Ernst-Jan M. Speel, Lizza E. L. Hendriks
Precision Cancer Medicine  
2020;
3:
22  
Case Report: Precision Oncology Tumor Board 
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Sayak Ghatak, Kevin Lin, Emil Lou, Andrew C. Nelson
Precision Cancer Medicine  
2020;
3:
21  
Review Article 
A narrative review of salvage therapy in small cell lung cancer
Saira Farid, Stephen V. Liu
Precision Cancer Medicine  
2020;
3:
20  
Review Article 
Prognostic impact of targetable genetic variants in resected adenocarcinoma of the lung: a narrative review and model proposal for precise evaluation
Masaoki Ito, Yoshihiro Miyata, Morihito Okada
Precision Cancer Medicine  
2020;
3:
19  
Editorial Commentary 
Current and future perspectives in lung cancer prevention
Adrián González-Marrón, Juan Carlos Martín-Sánchez, Jose M. Martínez-Sánchez
Precision Cancer Medicine  
2020;
3:
18  
Case Report: Precision Oncology Tumor Board 
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa
Precision Cancer Medicine  
2020;
3:
17  
Case Report 
Hepatic lymphoepithelioma-like carcinoma: a case report with literature review
Chunxiu Yang, Yueying Li, Yanyan Chen, Shu-Yuan Xiao
Precision Cancer Medicine  
2020;
3:
16  
Review Article 
Nutrition, disease and underlying molecular mechanisms
Aamer M. Qazi, Rabia Tabassum, Fatima Arshad, Aysha Shaukat, Warda Qazi, Muhammad Tahir Javaid, Abdul Manan
Precision Cancer Medicine  
2020;
3:
15  
Review Article 
NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)
Alessandro Russo, Ana Rita Lopes, Katherine Scilla, Ranee Mehra, Vincenzo Adamo, Julio Oliveira, Stephen V. Liu, Christian Rolfo
Precision Cancer Medicine  
2020;
3:
14  
Original Article 
Factors associated with the extent of resection of glioblastoma
Thara Tunthanathip, Suphavadee Madteng
Precision Cancer Medicine  
2020;
3:
12  
Editorial Commentary 
Cancer immunotherapy: lessons from the parasites to improve fighting against tumors
Alexandre Morrot
Precision Cancer Medicine  
2020;
3:
11  
Case Report: Precision Oncology Tumor Board 
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Stephen Zachary Peeke, Robert Lopez, Benjamin Gartrell
Precision Cancer Medicine  
2020;
3:
10  
Case Report: Precision Oncology Tumor Board 
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Jose N. Galeas, Nishi Shah, Shabnam Ridvi, Jennifer Chuy
Precision Cancer Medicine  
2020;
3:
9  
Case Report: Precision Oncology Tumor Board 
Targeting EGFR mutations needs to be more precise with co-mutations
Paul R. Walker, Nitika Sharma, Praveen Namireddy
Precision Cancer Medicine  
2020;
3:
8  
Review Article 
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik
Precision Cancer Medicine  
2020;
3:
7  
Review Article 
Annotating the next generation sequencing report
Miguel A. Molina-Vila, Clara Mayo-de-las-Casas, Mónica Garzón-Ibáñez, Núria Jordana-Ariza, Beatriz García-Peláez, Ariadna Balada-Bel, Rafael Rosell
Precision Cancer Medicine  
2020;
3:
6  
Review Article 
Non-small cell lung cancer targetable mutations: present and future
Peter Vu, Sandip Pravin Patel
Precision Cancer Medicine  
2020;
3:
5  
Review Article 
Circulating tumor cells: moving forward into clinical applications
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières
Precision Cancer Medicine  
2020;
3:
4  

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa